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Lidocaine-anesthesiaAbstract Purpose: Propofol has become one of the most common anesthetic agents used for anes-
thesia because of its unique pharmacologic properties. Pain during bolus injection is a major draw-
back of propofol. The target of this study was to study the effect of lidocaine used in a large volume
on prevention of propofol injection pain. Our hypothesis is that IV administration of diluted lido-
caine in a large volume before propofol injection could be more effective in prevention of both
immediate and delayed types of pain associated with propofol injection than the most commonly
used method of mixing lidocaine with propofol (30 mg lidocaine/added to the 20 ml propofol syr-
inge).
Methods: 100 Patients with age range (20–60) years and classiﬁed ASA1 and ASA2 undergoing
general anesthesia for elective surgery were included in this study. Patients were classiﬁed into
two groups, the ﬁrst (study) group, in which 30 mg lidocaine diluted into a total volume of 20 ml
using normal saline was given IV after venous occlusion with rubber tourniquet followed by pro-
pofol injection. In the second (control) group, 30 mg lidocaine was mixed with propofol and given
to the patient as commonly used.
Results: This study showed a highly signiﬁcant reduction in the propofol injection pain in the study
group compared to the control group.
292 A.M. ShabanaConclusion: lidocaine when given diluted in a large volume after venous occlusion has dramatically
reduced propofol injection pain in adults.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.Table 1 The withdrawal response score.
Degree of
movements
Patient response
0 No response or withdrawal
1 Movement at the wrist only
2 Movement/withdrawal involving arm only
3 Generalized response-withdrawal or movement in
more than one extremity, cough or breath holding
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Propofol has become one of the most common anesthetic
agents used for sedation, induction, and maintenance of anes-
thesia because of its unique pharmacological properties. Pain
during bolus injection is a major drawback of propofol. Pro-
pofol belongs to a group of phenol that can irritate the skin,
mucous membrane, and venous intima. Pain on injection of
propofol can be immediate or delayed [1]. Immediate pain
may be caused by direct irritation of afferent nerve ending
within the veins, whereas delayed pain probably results from
an indirect effect via the kinin cascade. Bradykinin, by produc-
ing local vasodilatation and hyper-permeability, may increase
the contact between the aqueous phase propofol and the peri-
vascular free nerve ending resulting in pain on injection. This
pain has a 10–20 s delayed onset.
There are many methods to prevent or to reduce the pain of
propofol injection. Mixing lidocaine with propofol is the most
commonly used method among all methods and techniques
studied for prevention of propofol injection pain.
In this work, we will study the effect of diluted lidocaine
pretreatment after venous occlusion with tourniquet on Pro-
pofol-Lipuro 1% (B. Braun, Melshungen AG, Germany),
injection pain. Our hypothesis is that IV administration of
diluted lidocaine in a large volume (30 mg lidocaine diluted
in a 20 ml normal saline) before propofol injection could be
more effective in prevention of both immediate and delayed
types of pain associated with propofol injection than the
most commonly used method of mixing lidocaine with pro-
pofol (30 mg lidocaine/added to the 20 ml propofol syringe).
Lidocaine diluted in such volume and injected during venous
occlusion may give a chance for larger volume of the drug
to spread over larger surface area to block more pain pro-
ducing nerve endings, not only within the veins, but also
bypassing to block perivascular nerve endings, which could
prevent both immediate and delayed types of pain caused
by propofol respectively.
2. Methods
This prospective randomized controlled double-blind study
was conducted on 100 consecutive patients with age range
20–60. A written consent was taken that the research was ap-
proved from the responsible authorities.
Patients classiﬁed ASA1 and ASA2 undergoing general
anesthesia for elective surgery were included. Patients with
known history of allergy to either propofol or lidocaine were
excluded. Eligible patients were randomly allocated using com-
puter generated-randomized test to one of two equal groups:
the study group and the control group.
All patients were premedicated with midazolam tablet
3.75 mg about 30 min preinduction and cannulated with a
20 gauge intravenous cannula on the distal part of the forearm.
On arrival to the operation room, all patients were moni-
tored with electrocardiogram, pulse oximetry, non-invasivearterial blood pressure, and capnography (after endotracheal
intubation). Mean arterial blood pressure and heart rate were
recorded for statistical comparison between the two groups at
baseline, just before intubation, and 1 min after intubation.
Both groups were subjected to the same anesthetic manage-
ment. In the study group, a 30 mg lidocaine diluted with sterile
saline into a total volume of 20 mL was injected intravenously
after venous occlusion. We used a very simple fast non-inva-
sive method for occlusion of venous out ﬂow through the
use of the tourniquet used for non-invasive BP measurement
limiting inﬂation pressure to just above 50 mmHg (seen on
monitor), using a clamp in order to be sure that venous out-
ﬂow was completely restricted.
The tourniquet was placed around the middle of the arm
[2], which was maintained 90 s after lidocaine injection, and
then after release of the tourniquet, propofol in a dose of
2 mg/kg was injected slowly over 30 s.
In the second group (control), tourniquet was applied sim-
ilarly like the study group and a total volume of 20 mL of ster-
ile normal saline without any drug addiction was served as a
placebo, so the anesthesia providers administering the propo-
fol would still remain blinded to the mixed or unmixed propo-
fol. After tourniquet release, propofol mixed with 30 mg
lidocaine (total volume 20 ml) was injected in a dose of
2 mg/kg over 30 s.
Each dose was prepared by one of the researchers in the
operating room immediately prior to induction but was given
by the attending anesthesia providers, who were blinded to the
content of each syringe.
Assessment of pain during and within 1 min after propofol
injection was done objectively using the withdrawal response
score proposed by Shevchenko and his colleagues [3] according
to Table 1. A researcher who was unaware of group assign-
ment assessed the pain according to the score grading.
After propofol injection, and pain assessment, fentanyl
1 lg/kg and tracrium 0.5 mg/kg were given. Intubation was
done 3 min after tracrium administration; anesthesia was
maintained by a mixture of nitrous oxide and oxygen supple-
mented with isoﬂorane. Muscle relaxation was maintained by
increments of tracrium. At the end of the procedure, muscle
relaxant was reversed by neostigmine and atropine.
Statistical analysis was performed using the Statistical
Package for the Social Sciences (SPSS for Windows, version
17). While intergroup parametric data were compared by the
independent sample-t test, nonparametric data were compared
by Mann Whitney test.
Table 2 Total number of cases associated with pain in both
groups represented by absolute number and percentage and the
highest score recorded in each group.
Group No of cases
with pain
Highest score
recorded
Incidence
of pain (%)
Study 2 1 4
Control 12 3 24
Table 3 Demographic data and operative time in both study
and control groups. Values for age, weight, and operative time
are mean (SD) and for sex represented by absolute number of
cases.
Study group Control group
Age (yr) 32.4 (11.9) 33.5 (10.8)
Weight (kg) 75.3 (13.9) 78.1 (9.8)
Operative time 93.2 (50.4) 96.9 (47.9)
Sex 55 M 5 F 54 M 6
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Figure 1 Mean arterial blood pressure (MAP) and heart rate
(HR) measurements in study and the control groups, where
pre = preintubation and post = postintubation.
Prevention of propofol injection pain 293Signiﬁcance level was set at p< 0.05. Incidence of propofol
injection pain was also presented by percent (%) in both
groups.
3. Results
This study showed a highly signiﬁcant reduction in the with-
drawal movements in the study group (median score 0.22)
compared to the control group (median score 1.5) with p value
0.001. The incidence of pain in the study group was 4% (2 pa-
tients) and the number of patients who recorded highest score
was 1, while in the control group, the incidence of pain with
propofol injection was 24% (12 patients) and the number of
patients who recorded highest score were three (Table 2). All
patients tolerated 50 mmHg tourniquet cuff pressure for
2 min without discomfort.
The groups’ demographic data did not signiﬁcantly differ
(Table 3). Table 3 demonstrates the operation list and the
number of cases. Basal and preintubation mean arterial blood
pressure measurements showed no statistical signiﬁcance be-
tween the two groups. There was a signiﬁcant reduction ofthe postintubation mean arterial blood pressure in the study
group (mean = 75.2) compared to that of the control group
(mean = 79.3) with p value 0.037. Basal, preintubation, and
postintubation heart rate measurements showed no statistical
signiﬁcance between the two groups (Fig. 1).
4. Discussion
This study clearly demonstrated a highly signiﬁcant reduction
in the propofol injection pain evidenced by marked decrease in
the withdrawal movements in the study group (median score
0.22) compared to the control group (median score 1.5) with
p value 0.001. We used an objective method for assessment
of pain because it may be more reliable than subjective meth-
ods especially in patients under sedation, and pain-related
withdrawal movements occur even after loss of consciousness
during induction of anesthesia which gives us time to assess
pain.
Propofol is now widely used for both anesthesia and seda-
tion because of its high quality of anesthesia with rapid recov-
ery in addition to the very useful antiemetic property. Pain on
injection with propofol is a common well recognized problem,
and it can be very distressing to the patient. Propofol belong to
group of phenol that can irritate the skin, mucous membrane,
and venous intema [1]. Pain on injection of propofol can be
immediate or delayed. Immediate pain may be caused by direct
irritation of afferent nerve ending within the veins, whereas de-
layed pain probably caused by activation of the kallikrein–ki-
nin system either by propofol or by the lipid solvent, there by
generating kinins, probably bradykinin. Bradykinin, by pro-
ducing local vasodilation and hyper-permeability, may in-
crease the contact between the aqueous phase propofol and
the free nerve ending resulting in pain on injection. This pain
has a 10–20 s delayed onset.
The incidence of propofol injection pain without use of any
analgesic intervention according to previous published studies
[4–6] is approximately 80%. The younger the patient, the high-
er is the incidence and severity of propofol injection pain [7].
There are different factors that may augment this type of
pain including site of injection, the temperature of the propofol
solution, size of the vein, and speed of injection. In this study,
we had tried to control and ﬁx these factors in both groups as
much as possible. Different methods and techniques were tried
in order to attenuate propofol injection pain including warm-
ing [8] or cooling of propofol [9] and using larger antecubital
and forearm veins [10]. Furthermore, multiple agents have
been administered as either pretreatment or given concurrently
including: thiopentone [6], ondansetron [1], alfentanil [11],
remifentanil [12], metoclopramide [13], magnesium sulfate
[5], and ketamine [14]. Among these studies, two of the most
commonly accepted techniques are the administration of lido-
caine immediately prior to the injection of propofol or mixing
lidocaine with the propofol itself.
Propofol-Lipuro 1% is newer formulation (B. Braun,
Melshungen AG, Germany) that was produced as a trial to
prevent propofol injection pain which is evidenced by Sun
and his colleagues [15]. However, based on other studies
[16,17], it can be said that Propofol-Lipuro offers some
advantage over the older drug Diprivan 1% (AstraZeneca,
Cheshire, UK) concerning injection pain. This advantage
might probably be smaller than what was previously sug-
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lidocaine, preinjecting opioids, or use of large veins at forearm
or even antecubital fossa seem indicated with Propofol-Lip-
uro too.
In a quantitative systematic review, Picard and Tramer [4]
compared three different methods of using lidocaine in preven-
tion of propofol pain. The ﬁrst was lidocaine bolus injection
before propofol injection. Second was mixing lidocaine with
propofol, and the third by giving lidocaine after venous occlu-
sion with tourniquet. They reported that using the tourniquet
was the most effective method.
We studied lidocaine pretreatment because propofol pain
may hinder smooth induction of anesthesia which is associated
with patient agitation and enhancement of the stress response,
so pretreatment for prevention of this pain become the stan-
dard technique in anesthesia practice. Overbaugh et al. [18]
concluded that lidocaine more effectively reduces pain on
injection of propofol when it is administered as a mixture than
when given as a pretreatment before the propofol injection.
Our technique is different because of using markedly diluted
lidocaine under tourniquet which may explain the different re-
sult between our study and Overbaugh et al. study [18]. The
present study was both cost and time effective as it can be used
during the period of preoxygenation.
In this study, the reduction of the preintubation and post-
intubation measurements of mean arterial blood pressure
and heart rate in the study group compared to the control
one could be explained by attenuation of the stress response
as a result of reduction of the propofol injection pain in the
study group.
5. Conclusion
Pretreatment with lidocaine diluted in a large volume under ve-
nous tourniquet dramatically reduced propofol injection pain
in adult patients; this method is easy to apply, with no time
wastage, without adding cost. Also we can say that reduction
of propofol injection pain was associated with smooth anesthe-
sia induction and attenuation of the stress response.
References
[1] Ambesh SP, Dubey PK, Sinha PK. Ondansetron pretreatment
to alleviate pain on propofol injection: a randomized,
controlled, double blinded study. Anaesth Analg 1999;89:197–9.
[2] Mangar D, Holak EJ. Tourniquet at 50 mmHg followed by
intravenous lidocaine diminishes hand pain associated with
propofol injection. Anaesth Analg 1992;74:250–2.[3] Shevchenko Y, Jocson JC, McRae VA, Stayer SA, Schwartz
RE, Rehman M, Choudhry DK. The use of lidocaine for
preventing the withdrawal associated with the injection of
rocuronium in children and adolescents. Anesth Analg
1999;88:746–8.
[4] Picard P, Tramer MR. Prevention of pain on injection with
propofol: quantitative systematic review. Anesth Analg
2000;90:963–9.
[5] Memis D, Turan A, Karamaniloglu B, Su¨t N, Pamukc¸u Z. The
use of magnesium sulphate to prevent pain on injection of
propofol. Anesth Analg 2002;95:606–8.
[6] Agarwal A, Ansari MF, Gupta D, Pandey R, Raza M, Singh
PK. Pretreatment with thiopental for prevention of pain
associated with propofol injection. Anesth Analg 2004;98:683–6.
[7] Cameron E, Johnston G, Cfofts S, Mortan NS. The minimum
effective dose of lignocaine to prevent injection pain due to
propofol in children. Anaesthesia 1992;47:604–6.
[8] Fletcher G, Gillespie J, Davidson J. The effect of temperature
upon pain during injection of propofol. Anaesthesia
1996;51:498–9.
[9] Barker P, Langton JA, Murphy P, Rowbotham J. Effects of
prior administration of cold saline on pain during propofol
injection. Anaesthesia 1991;46:1069–70.
[10] Seddon SJ. Pain on injection of propofol (letter). Anaesthesia
1997;52:276–90.
[11] Fletcher J, Seavall C, Bowen D. Pretreatment with alfentanil
reduces pain caused by propofol. Br J Anaesth 1994;72:342–4
(s).
[12] Kwak K, Kim J, Park S, Lim D, Kim S, Baek W, Jeon Y.
Reduction of pain on injection of propofol: combination of
pretreatment of remifentanil and premixture of lidocaine with
propofol. Eur J Anaesthesiol 2007;24:746–50.
[13] Fujii Y, Nakayama M. A lidocaine/metoclopramide
combination decreases pain on injection of propofol. Can J
Anesth 2005;52:474–7.
[14] Kad N, Malik P, Dureja J, Thakur A. Ketamine pretreatment to
alleviate the pain of propofol injection: a randomized, double
blind study. Internet J Anesthesiol 2009;20(2).
[15] Sun HC, Wong CY, Irwin GM. A comparison of pain on
intravenous injection between two preparations of propofol.
Anaesth Analg 2005;101:675–8.
[16] Schaub E, Kern C, Landau R. Pain on injection: a double-blind
comparison of propofol with lidocaine pretreatment versus
propofol formulated with long- and medium-chain triglycerides.
Anesth Analg 2004;99:1699–702.
[17] Rau J, Roizen M, Doenicke AW, O’Connor MF,
Strohschneider U. Propofol in an emulsion of long- and
medium-chain triglycerides: the effect on pain. Anesth Analg
2001;93:382–4.
[18] Overbaugh R, Jones P, Nguyen A. Effect of mixed versus
unmixed lidocaine with propofol. Internet J Anesthesiol
2003;7(2).
